Hemoglobin-based oxygen carriers: Current status and future directions

Anesthesiology

Volumn 111, Issue 5, 2009, Pages 946-963

  Silverman, Toby A ^a   Weiskopf, Richard B ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DCL HEMOGLOBIN; DIASPIRIN CROSSLINKED HEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN MP4; HEMOGLOBIN POE; HEMOSPAN; LEVESINEX; MACROGOL; NITRITE REDUCTASE; OXYGEN; PLACEBO; POLYHEMOGLOBIN BV; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN; RECOMBINANT HEMOGLOBIN 1.1; RECOMBINANT HEMOGLOBIN 2; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; ARTERY THROMBOSIS; BIOCHEMISTRY; BIOPHYSICS; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD PRESSURE; BRADYCARDIA; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOPULMONARY ARREST; CARDIOPULMONARY INSUFFICIENCY; CENTRAL VENOUS PRESSURE; CEREBROVASCULAR ACCIDENT; CHEST TIGHTNESS; CLINICAL TRIAL; CONFLICT OF INTEREST; CONGESTIVE HEART FAILURE; CYANOSIS; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DUODENAL ULCER BLEEDING; DYSPEPSIA; DYSPHAGIA; DYSPNEA; ENGINEERING; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERUCTATION; ESOPHAGUS SPASM; FIBRINOGEN BLOOD LEVEL; FOOD AND DRUG ADMINISTRATION; GASTRIC ULCER BLEEDING; GASTROINTESTINAL PAIN; HEALTH CARE ORGANIZATION; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HEART INDEX; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART OUTPUT; HEART VENTRICLE FIBRILLATION; HEMIPARESIS; HEMIPLEGIA; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC SHOCK; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOTENSION; HYPOVOLEMIA; HYPOXIA; ILEUS; INFORMATION; LIVER FUNCTION TEST; LUNG EDEMA; LUNG EMBOLISM; MALIGNANT HYPERTENSION; MICROVASCULATURE; MULTIPLE ORGAN FAILURE; NAUSEA; NONHUMAN; OXYGEN SATURATION; OXYGEN TRANSPORT; PANCREATITIS; PEPTIC ULCER BLEEDING; PETECHIA; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PURPURA; RECTUM HEMORRHAGE; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RETCHING; REVIEW; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; THORAX PAIN; THROMBOCYTHEMIA; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHLEBITIS; THROMBOSIS; TIME; TRANSIENT ISCHEMIC ATTACK; VAGINA BLEEDING; VISCOSITY; VOMITING;

EID: 70350441470     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181ba3c2c     Document Type: Article

References (87)

1. Jia L, Bonaventura C, Bonaventura J, Stamler JS: S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 1996; 380:221-226 (Pubitemid 26090643)
2. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT: Nitrite reduction to nitric oxide by deoxyhe-moglobin vasodilates the human circulation. Nat Med 2003; 9:1498-1505
3. Winslow RM: Targeted O2 delivery by low-p50 hemoglobin: A new basis for hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 2005; 33:1-12
4. Tsai AG, Vandegriff KD, Intaglietta M, Winslow RM: Targeted O2 delivery by low-P50 hemoglobin: A new basis for O2 therapeutics. Am J Physiol Heart Circ Physiol 2003; 285:H1411-9
5. Cabrales P, Tsai AG, Winslow RM, Intaglietta M: Extreme hemodilution with PEG-hemoglobin versus PEG-albumin. Am J Physiol Heart Circ Physiol 2005; 289:H2392-400
6. Hare GM, Hum KM, Kim SY, Barr A, Baker AJ, Mazer CD: Increased cerebral tissue oxygen tension after extensive hemodilution with a hemoglobin-based oxygen carrier. Anesth Analg 2004; 99:528-535
7. Torres Filho IP, Spiess BD, Barbee RW, Ward KR, Oldenhof J, Pittman RN: Systemic responses to hemodilution after transfusion with stored blood and with a hemoglobin-based oxygen carrier. Anesth Analg 2005; 100:912-920
8. Hungerer S, Nolte D, Botzlar A, Messmer K: Effects of Diaspirin Crosslinked Hemoglobin (DCLHb) on microcirculation and local tissue pO2 of striated skin muscle following resuscitation from hemorrhagic shock. Artif Cells Blood Substit Immobil Biotechnol 2006; 34:455-471
9. Ding H, Triggle C: Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: Assessing the health of the endothelium. Vasc Health Risk Manag 2005; 1:55-71
10. Endemann DH, Schiffrin EL: Endothelial dysfunction. J Am Soc Nephrol 2004; 15:1983-1992
11. Esper RJ, Nordaby RA, Vilarino JO, Paragano A, Cacharron JL, Machado RA: Endothelial dysfunction: A comprehensive appraisal. Cardiovasc Diabetol 2006; 5:4
12. Emanuel EJ, Wendler D, Grady C: What makes clinical research ethical? JAMA 2000; 283:2701-2711
13. Vandegriff K, Young M, Keipert P, Winslow R: The safety profile of Hemospan®: a new oxygen therapeutic designed using maleimide poly(ethylene) glycol conjugation to human hemoglobin. Transfus Altern Transfus Med 2008; 9:213-225
14. Winslow RM: Red cell substitutes. Semin Hematol 2007; 44:51-59
15. Olofsson C, Ahl T, Johansson T, Larsson S, Nellgard P, Ponzer S, Fagrell B, Przybelski R, Keipert P, Winslow N, Winslow RM: A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified Hemoglobin (Hemospan) in patients undergoing major orthopedic surgery. ANESTHESIOLOGY 2006; 105:1153-1163
16. Olofsson C, Nygards EB, Ponzer S, Fagrell B, Przybelski R, Keipert PE, Winslow N, Winslow RM: A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia. Transfus Med 2008; 18:28-39
17. Gould SA, Moore EE, Hoyt DB, Ness PM, Norris EJ, Carson JL, Hides GA, Freeman IH, DeWoskin R, Moss GS: The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 2002; 195:445-52; discussion 452-455
18. Carson JL, Noveck H, Berlin JA, Gould SA: Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002; 42:812-818
19. Moore EE, Cheng AM, Moore HB, Masuno T, Johnson JL: Hemoglobin-based oxygen carriers in trauma care: Scientific rationale for the US multicenter prehosptial trial. World J Surg 2006; 30:1247-1257
20. Dunnett CW, Gent M: An alternative to the use of two-sided tests in clinical trials. Stat Med 1996; 15:1729-1738
21. Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG: HBOC-201 as an alternative to blood transfusion: Efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma 2008; 64:1484-1497
22. Kerner T, Ahlers O, Veit S, Riou B, Saunders M, Pison U: DCL-Hb for trauma patients with severe hemorrhagic shock: the European "On-Scene" mul-ticenter study. Intensive Care Med 2003; 29:378-385
23. Sloan EP, Koenigsberg M, Brunett PH, Bynoe RP, Morris JA, Tinkoff G, Dalsey WC, Ochsner MG: Post hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemor-rhagic shock. J Trauma 2002; 52:887-895
24. Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, Rodman G Jr: Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial. JAMA 1999; 282:1857-1864
25. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, Williams KL, Park MS: Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248:447-458
26. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM: Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis. JAMA 2008; 299:2304-2312
27. Ricci Z, Cruz D, Ronco C: The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 2008; 73:538-546
28. Viele MK, Weiskopf RB, Fisher D: Recombinant human hemoglobin does not affect renal function in humans: Analysis of safety and pharmacokinetics. ANESTHESIOLOGY 1997; 86:848-858
29. Solomon R, Segal A: Defining acute kidney injury: What is the most appropriate metric? Nat Clin Pract Nephrol 2008; 4:208-215
30. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, Bonventre JV, Jaber BL: Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18:904-912
31. Ronco C: N-GAL: Diagnosing AKI as soon as possible. Crit Care 2007; 11:173
32. Dong F, Hall CH, Golech SA, Philbin NB, Rice JP, Gurney J, Arnaud FG, Hammett M, Ma X, Flournoy WS, Hong J, Kaplan LJ, Pearce LB, McGwin G, Ahlers S, McCarron R, Freilich D: Immune effects of resuscitation with HBOC-201, a hemoglobin-based oxygen carrier, in swine with moderately severe hemorrhagic shock from controlled hemorrhage. Shock 2006; 25:50-55
33. Burhop K, Gordon D, Estep T: Review of hemoglobin-induced myocardial lesions. Artif Cells Blood Substit Immobil Biotechnol 2004; 32:353-374
34. Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ: Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 2007; 110: 2166-2172
35. Saxena R, Wijnhoud AD, Carton H, Hacke W, Kaste M, Przybelski RJ, Stern KN, Koudstaal PJ: Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999; 30:993-996
36. Qu Y, Chen J, Benvenisti-Zarom L, Ma X, Regan RF: Effect of targeted deletion of the heme oxygenase-2 gene on hemoglobin toxicity in the striatum. J Cereb Blood Flow Metab 2005; 25:1466-1475
37. Panter SS, Vandegriff KD, Yan PO, Regan RF: Assessment of hemoglobin-dependent neurotoxicity: Alpha-alpha crosslinked hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1994; 22:399-413
38. Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 2005; 293:1653-1662
39. Gladwin MT, Schechter AN, Kim-Shapiro DB, Patel RP, Hogg N, Shiva S, Cannon RO, Kelm M, Wink DA, Espey MG, Oldfield EH, Pluta RM, Freeman BA, Lancaster JR Jr, Feelisch M, Lundberg JO: The emerging biology of the nitrite anion. Nat Chem Biol 2005; 1:308-314
40. Huang Z, Shiva S, Kim-Shapiro DB, Patel RP, Ringwood LA, Irby CE, Huang KT, Ho C, Hogg N, Schechter AN, Gladwin MT: Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 2005; 115:2099-2107
41. Olson JS, Maillett DH: Designing recombinant hemoglobin for use as a blood substitute, Blood Substitutes. Edited by Winslow R. London, UK, Elsevier, 2005
42. Graves PE, Henderson DP, Horstman MJ, Solomon BJ, Olson JS: Enhancing stability and expression of recombinant human hemoglobin in E. coli: Progress in the development of a recombinant HBOC source. Biochim Biophys Acta 2008; 1784:1471-1479
43. Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP, Lemon DD: NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 2004; 36:685-697
44. Dou Y, Maillett DH, Eich RF, Olson JS: Myoglobin as a model system for designing heme protein based blood substitutes. Biophys Chem 2002; 98:127-148
45. Doherty DH, Doyle MP, Curry SR, Vali RJ, Fattor TJ, Olson JS, Lemon DD: Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 1998; 16:672-676
46. Cabales P, Friedman J: Pegylated hemoglobins mechanisms to avoid vaso-constriction and maintain perfusion. Transfus Altern Transfus Med 2008; 9:281-293
47. Acharya S, Intaglietta M, Tsai A: Modulation of the PEH-Hb structure to increase the efficiency of plasma expansion and O2 carrying capacity. Transfus Altern Transfus Med 2007; 9:254-264
48. Fleming TR: Identifying and addressing safety signals in clinical trials. N Engl J Med 2008; 359:1400-1402
49. Severinghaus JW: Oxyhemoglobin dissociation curve correction for temperature and pH variation in human blood. J Appl Physiol 1958; 12:485-486
50. Severinghaus JW: Blood gas calculator. J Appl Physiol 1966; 21:1108-1116
51. Sullivan B, Riggs A: Data for constructing blood oxygen dissociation curves, Resiration and Circulation. Edited by Altman PL, Dittmer DS. Bethesda, Federation of American Societies for Experimental Biology, 1971
52. Nelson D, Hai T, Srnak A, Ebeling A, Kunas G, Catarello J, Burhop K: Synthesis and properties of polymerized, diaspirin cross-linked hemoglobins. Biomater Artif Cells Immobilization Biotechnol 1992; 20:253-258
53. Privalle C, Talarico T, Keng T, DeAngelo J: Pyridoxalated hemoglobin polyoxyethylene: A nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock. Free Radic Biol Med 2000; 28:1507-1517
54. Nelson DJ: DCLHb and rHb1.1, Blood Substitutes. Edited by Winslow RM. London, UK, Academic Press, Elsevier Inc., 2006
55. Vandegriff KD, Malavalli A, Wooldridge J, Lohman J, Winslow RM: MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 2003; 43:509-516
56. Kramer GC, Nascimento PJ, Vaid SU: Hemoglobin-based oxygen carriers as resuscitative solutions for trauma and combat casualty care, Blood Substitutes. Edited by Winslow RM. London, UK, Academic Press, Elsevier Inc., 2006
57. Talarico TL, Guise KJ, Stacey CJ: Chemical characterization of pyridox-alated hemoglobin polyoxyethylene conjugate. Biochim Biophys Acta 2000; 1476:53-65
58. Riess JG: Oxygen carriers ("blood substitutes")-raison d'etre, chemistry, and some physiology. Chem Rev 2001; 101:2797-2920
59. Wicks D, Wong LT, Sandhu R, Stewart RK, Biro GP: The intravascular persistence and methemoglobin formation of Hemolink (hemoglobin raffimer) in dogs. Artif Cells Blood Substit Immobil Biotechnol 2003; 31:1-17
60. Spahn D, Chassot P-G: Clinical trials in cardiac surgery, Blood Substitutes. Edited by Winslow RM. London, UK, Academic Press, Elsevier Inc., 2006
61. Rentko VT, Pearce LB, Moon-Massat PF, Gawryl MS: HBOC-201 (hemoglobin glutamer-250 (Bovine), Hemopure®): Clinical studies, Blood Substitutes. Edited by Winslow RM. London, UK, Academic Press, Elsevier Inc., 2006
62. Winslow RM: Hemoglobin modification, Blood Substitutes. Edited by Win-slow RM. London, UK, Academic Press, Elsevier Inc., 2006
63. Swan SK, Halstenson CE, Collins AJ, Colburn WA, Blue J, Przybelski RJ: Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. Am J Kidney Dis 1995; 26:918-923
64. Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colburn WA: Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med 1996; 24:1993-2000
65. Bloomfield EL, Rady MY, Esfandiari S: A prospective trial of diaspirin cross-linked hemoglobin solution in patients after elective repair of abdominal aortic aneurysm. Mil Med 2004; 169:546-550
66. Schubert A, Przybelski RJ, Eidt JF, Lasky LC, Marks KE, Karafa M, Novick AC, O'Hara JF Jr, Saunders ME, Blue JW, Tetzlaff JE, Mascha E: Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: A multicenter, randomized, controlled, double-blinded trial. Anesth Analg 2003; 97:323-332
67. Ward CG, Sloan EP: Post hoc mortality analysis on the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemor-rhagic shock. J Trauma 2002; 53:1031; author reply 1031-1032
68. Lamy ML, Daily EK, Brichant JF, Larbuisson RP, Demeyere RH, Vander-meersch EA, Lehot JJ, Parsloe MR, Berridge JC, Sinclair CJ, Baron JF, Przybelski RJ: Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. ANESTHESIOLOGY 2000; 92:646-656
69. Garrioch MA, McClure JH, Wildsmith JA: Haemodynamic effects of diaspi-rin crosslinked haemoglobin (DCLHb) given before abdominal aortic aneurysm surgery. Br J Anaesth 1999; 83:702-707
70. Saxena R, Wijnhoud AD, Man in't Veld AJ, van den Meiracker AH, Boomsma F, Przybelski RJ, Koudstaal PJ: Effect of diaspirin cross-linked hemoglobin on endothelin-1 and blood pressure in acute ischemic stroke in man. J Hypertens 1998; 16:1459-1465
71. Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ: Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med 1997; 25:1480-1488
72. Sprung J, Kindscher JD, Wahr JA, Levy JH, Monk TG, Moritz MW, O'Hara, PJ: The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: Results of a multicenter, randomized, single-blinded trial. Anesth Analg 2002; 94:799-808
73. LaMuraglia GM, O'Hara PJ, Baker WH, Naslund TC, Norris EJ, Li J, Vander-meersch E: The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 2000; 31:299-308
74. Standl T, Burmeister MA, Horn EP, Wilhelm S, Knoefel WT, Schulte am Esch J: Bovine haemoglobin-based oxygen carrier for patients undergoing hae-modilution before liver resection. Br J Anaesth 1998; 80:189-194
75. Kasper SM, Grune F, Walter M, Amr N, Erasmi H, Buzello W: The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1998; 87:284-291
76. Kasper SM, Walter M, Grune F, Bischoff A, Erasmi H, Buzello W: Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996; 83:921-927
77. Levy JH: The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss. Expert Opin Biol Ther 2003; 3:509-517
78. Levy JH, Goodnough LT, Greilich PE, Parr GV, Stewart RW, Gratz I, Wahr J, Williams J, Comunale ME, Doblar D, Silvay G, Cohen M, Jahr JS, Vlahakes GJ: Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002; 124:35-42
79. Serruys P, Vranckx P, Slagboom T, Regar E, Meliga E, de Winter R, Heyndrickx G, Schuler G, van Remortel E, Dubé GP, Symons J: Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention 2008; 3:600-609
80. Greenburg AG, Kim HW: Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery. J Am Coll Surg 2004; 198:373-83; discussion 384-385
81. Hill SE, Gottschalk LI, Grichnik K: Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2002; 16:695-702
82. Carmichael FJ, Ali AC, Campbell JA, Langlois SF, Biro GP, Willan AR, Pierce CH, Greenburg AG: A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med 2000; 28:2283-2292
83. Johnson JL, Moore EE, Offner PJ, Haenel JB, Hides GA, Tamura DY: Resuscitation of the injured patient with polymerized stroma-free hemoglobin does not produce systemic or pulmonary hypertension. Am J Surg 1998; 176: 612-617
84. Gould SA, Moore EE, Moore FA, Haenel JB, Burch JM, Sehgal H, Sehgal L, DeWoskin R, Moss GS: Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery. J Trauma 1997; 43:325-31; discussion 331-332
85. Gould SA, Moore EE, Hoyt DB, Burch JM, Haenel JB, Garcia J, DeWoskin R, Moss GS: The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998; 187:113-20; discussion 120-122
86. Hayes JK, Stanley TH, Lind GH, East K, Smith B, Kessler K: A double-blind study to evaluate the safety of recombinant human hemoglobin in surgical patients during general anesthesia. J Cardiothorac Vasc Anesth 2001; 15:593-602
87. Li X-Z, Yang Q-H, Yan J-F, Xu K, Liu J, He X-Y, Zhang X-W, Liu Q: Characterization of poly(ethylene glycol)-modified bovine hemoglobin by capillary zone electrophoresis. Artif Cells Blood Substit Immobil Biotechnol 2007; 35:1-10